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Aims To determine how excessive daytime sleepiness (EDS) and impaired cognition contribute to health-related quality of
life (HRQL) in heart failure (HF).
Methods
and results
Adults with chronic HF were enrolled into a prospective cohort study. Data were obtained from 280 subjects en-
rolled from three sites in the northeastern USA; 242 completed the 6-month study. At baseline, cohorts with and
without EDS were identified using the Epworth Sleepiness Scale. Each EDS group was further subdivided into
those with and without impaired cognition using a battery of five neuropsychological tests. Two disease-specific mea-
sures, the Kansas City Cardiomyopathy Questionnaire (KCCQ) and the Functional Outcomes of Sleep Questionnaire
(FOSQ), were used to measure HRQL. General linear modelling of square-transformed variables was used to test the
hypothesis that cohort membership was a significant predictor of HRQL. At 6 months the remaining sample was 62.5
[standard deviation (SD) 12] years old, mostly male (63%), white (65%), and functionally compromised [72%
New York Heart Association (NYHA) class III/IV]. The cohort with both EDS and impaired cognition had the
lowest KCCQ overall summary score (60.5+22.5) compared with the cohort without EDS or impaired cognition
(74.6+17.4, P ≤ 0.001). A similar effect was seen on the FOSQ (16.0+ 2.8 vs. 18.5+2.2, P , 0.001).
Conclusion Impaired cognition alone did not explain poor HRQL, but the addition of EDS poses a significant risk for poor HRQL.
Interventions designed to influence EDS may improve HRQL in this population.
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Introduction
Poor health-related quality of life (HRQL) is more common in
adults with heart failure (HF) than in age- and gender-matched
controls.1 Individuals with HF have been noted to have worse
HRQL than those with cancer or other serious illnesses.2 In
advanced HF, HRQL that fails to improve within 1 month after hos-
pital discharge predicts a shortened time to subsequent hospital-
ization or death.3
A variety of factors have been identified as being associated
with the poor HRQL of HF, including symptom burden and cog-
nitive impairment.4 Although poor sleep quality has been shown
to be significantly correlated with impairments in HRQL in other
patient populations,5 it has only recently been recognized as a
contributor to poor HRQL in HF. Redeker and Hilkert found
that self-reported sleep quality and lack of sleep continuity
were associated with impaired HRQL in stable systolic HF
patients.6 In another study, HF patients who had difficulties
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maintaining sleep, initiating sleep, and early morning awakenings
had reduced HRQL.7
Numerous individual contributors to poor HRQL have been
identified, but these contributors rarely occur in isolation. A
recent study explored the contribution of impaired cognition to
poor HRQL in adults with HF.8 They found that HF severity,
age, depressive symptoms, and total recall memory explained
55% of the variance in HRQL, but the individual contribution of
memory to the amount of variance in HRQL explained was
minimal (1%). However, in previous work, we found that impaired
cognition was commonly associated with poor sleep in adults with
HF.9 Therefore, the purpose of this study was to determine how
excessive daytime sleepiness (EDS) and impaired cognition to-
gether contribute to poor HRQL in HF.
Background
Heart failure patients commonly report difficulties initiating and
maintaining sleep.7 A majority report poor sleep quality,10 and
many have poor sleep continuity.11 Half of HF patients report
insomnia-related symptoms, including EDS.12 In one sample, the
most frequently reported problems were inability to sleep flat
(51%), restless sleep (44%), trouble falling asleep (40%), and awa-
kening early (39%).13
Numerous factors impair sleep and cause EDS, including
stress,14 insomnia,12 and nocturia. Ageing assuredly contributes;
as we age, sleep becomes fragmented, with an increase in superfi-
cial sleep [non-rapid eye movement (NREM)] stage 1 and 2 and a
decrease in deep, slow wave sleep (NREM stage 3 and 4) and REM
sleep. In adults with HF, sleep-disordered breathing is common but
not consistently associated with either EDS or poor HRQL.15 Re-
gardless of the cause, poor sleep dulls cognitive processing, impair-
ing information processing, memory, vigilance, judgement,
motivation, and decision-making.16 The impact varies depending
on the severity of the sleep interruption. However, even modest
sleep restriction (6 h/night) causes clear impairment in cognition
after 7 days; mild sleep fragmentation (e.g. nocturia) takes longer
to impair cognition.17
Methods
This was a pre-planned analysis from a prospective cohort comparison
study. The methods used in this study have been described in detail
previously and are summarized here.18 Subjects were enrolled from
three sites in the northeastern USA. Institutional review board approv-
al was obtained at each site and all subjects gave informed consent.
Data were obtained at enrolment, and at 3 and 6 months during
face-to-face visits. In all, 280 subjects were enrolled and 242 completed
the 6-month follow-up. Reasons for attrition included death (n ¼ 6),
too ill to continue (n ¼ 7), refusal to continue or withdrawal
(n ¼ 5), and loss to follow-up (n ¼ 20).
A prospective cohort design allowed us to have well-characterized
cohorts for testing hypotheses about the effects of EDS and impaired
cognition on HRQL. At baseline we identified a cohort with EDS and a
control group without EDS. These groups were further divided into
those with and without cognitive impairment, as described below.
The result was four groups or cohorts for comparison (Figure 1).
We hypothesized that cohort membership at enrolment would be a
significant predictor of HRQL 6 months later.
Sample
We enrolled adults with chronic HF confirmation based on echocardio-
graphic and clinical evidence. All participants had to be currently or pre-
viously symptomatic (stage C HF). Potential subjects had to be able to
participate in the study (i.e. adequate vision, hearing, and English liter-
acy). The Telephone Interview for Cognitive Status (TICS) was used
to ensure that we did not enrol anyone with frank dementia; anyone
with a TICS score below 24 was excluded.19 Otherwise eligible indivi-
duals were excluded if they lived in a long-term care setting or
worked nights or rotating shifts, or if they had renal failure requiring dia-
lysis, an imminently terminal illness, plans to move out of the area, or a
history of serious drug or alcohol abuse within the past year. Individuals
with major depression were excluded because EDS is a prominent
symptom of depression so it would be difficult to separate out the
two problems. Major depressive illness was screened first by a review
of the medical record; patients identified as having major depressive
illness were not invited to participate. In addition, everyone was
screened with the 9-item Patient Health Questionnaire (PHQ-9).20
Anyone reporting five or more of the nine symptoms on more than
half of the days in the past 2 weeks was excluded if one of the symptoms
was depressed mood or anhedonia. Most of the data were collected
during home visits and by abstraction from the medical record.
Measurement
Excessive daytime sleepiness was measured using the Epworth Sleepi-
ness Scale.21 Respondents rate the likelihood of falling asleep in eight
boring situations, such as sitting in a car as a passenger, using a 4-point
Likert scale ranging from never dozing (0) to high chance of dozing (3).
Test–re-test reliability (r ¼ 0.82) and internal consistency (a ¼ 0.88)
Figure 1 Graphic representation of the cohort allocation.
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have been established in addition to its single factor structure. Scores are
summed, with higher scores indicating higher sleepiness, or categorized
as sleepy or not sleepy. At a cut-off point of 11, the Epworth Sleepiness
Scale has a sensitivity of 93.5% and a specificity of 100% for distinguishing
pathological from normal sleepiness. However, adults with HF do not
report EDS as commonly as others,22 perhaps because of the sympathet-
ic stimulation associated with HF. So, to make sure that we capture some
variability in EDS, we used a cut-off point score ≥ 6 to indicate EDS on
the advice of the instrument author.
A battery of five neuropsychological tests measuring attention,
memory, and executive function was administered at enrolment and
used to allocate participants to cohorts.23 The battery included a
test of simple attention (Psychomotor Vigilance Task), complex atten-
tion (Trail Making Test B), processing speed (Digit Symbol Substitution
Test), working memory (Probed Recall Memory Task), and short-term
memory (Letter Number Sequencing test). The number of tests on
which subjects scored below their age-based norm was used as the
measure of cognitive status. Specifically, anyone scoring .1.5 standard
deviations (SDs) on two or more of the cognition tests was judged to
have impaired cognition.24
Health-related quality of life was measured with two disease-specific
measures, the Kansas City Cardiomyopathy Questionnaire (KCCQ)
and the Functional Outcomes of Sleep Questionnaire (FOSQ). The
KCCQ is a 23-item health status measure of physical limitation,
symptom frequency, severity, and change over time, overall quality
of life, social interference, and self-efficacy.25 Internal consistency of
the instrument ranges from 0.78 to 0.95 for all domains except self-
efficacy (a ¼ 0.62). Higher scores indicate better HRQL.
The FOSQ is a 30-item self-report measure designed to assess the
impact of EDS on HRQL.26 The FOSQ has established content validity,
test–re-test reliability (r ¼ 0.91), and internal consistency (a ¼ 0.96).
Higher scores indicate better HRQL.
Socio-demographic characteristics were self-reported at enrolment.
Most clinical information (e.g. co-morbid illnesses, HF type and dur-
ation) was gathered from the medical record. Co-morbidity was
scored using the Charlson Index; higher scores indicate more
co-morbid illnesses.27 To decrease subject burden, depression was
measured over time using the short form of the Patient Health
Questionnaire (PHQ-2). Information on symptoms in response to
activities was gathered by trained research assistants using a structured
interview.28 A single cardiologist used the interview data to assign a
New York Heart Association (NYHA) score for every subject.
Length of time with HF was based on information collected from a his-
torical search of each subject’s medical record.
Data on sleep-disordered breathing were obtained from the medical
record at the time of enrolment. If no documentation of recent poly-
somnography was found in the medical record, sleep was assessed in
the home using Embletta (Medcare, Buffalo, NY, USA), a sensitive
and specific screening device useful in quantifying the apnoea–
hypopnoea index (AHI) in persons with suspected sleep-disordered
breathing.29 Embletta data were scored by expert technicians. An
AHI ≥ 5 was used to classify subjects as having sleep-disordered
breathing.30 In addition, during each home visit, medicines were
noted and later categorized to identify those known to cause
daytime somnolence (e.g. sedative hypnotics).
Analysis
Graphical techniques were used to assess the distributional assump-
tions of the KCCQ overall summary score, the FOSQ total score,
and the subscales of both measures. Transformations to normality
were applied as necessary. Specifically, the KCCQ overall summary
score and the FOSQ total score were squared in order to meet
distribution assumptions for modelling. Linear mixed effects models
were used to model the square-transformed total scores on both
scales and transformed subscales that were approximately normally
distributed. Back-transformed estimates were also calculated in
order to interpret the effects on the original scale scores. Non-normal
subscales were modelled via generalized estimating equations with an
ordered, cumulative logit link. The primary analysis examined the
cohort differences in the outcome scores. Other potential covariates
such as NHYA class, income, depressive symptoms, perceived
health, and medication adherence were included in the model via a
backward stepwise technique. All models were adjusted for age,
race, income, gender, data collection occasion, and data collection
site. Analyses were performed using SAS 9.2.
Results
Descriptive details of the sample are shown in Table 1. Overall, the
sample was predominantely male, white, well-educated, and finan-
cially comfortable. Most participants were overweight and func-
tionally compromised. Significant demographic differences were
evident among the cohorts defined by the presence or absence
of cognitive impairment and EDS. The two cohorts with cognitive
impairment were older, less likely to be white, more likely to have
less than a high school education, and less likely to be employed
than either cohort without cognitive impairment. The cohort
with the highest perceived overall health had EDS but no cognitive
impairment. The number of co-morbid illnesses was highest in
those with cognitive impairment. Depression was highest in the
cohort with both EDS and impaired cognition. No differences in
the prevalence of sleep-disordered breathing or the number of
medications known to cause daytime somnolence were identified.
Table 2 describes how the HRQL total scores and subscales
changed over the course of the 6-month study. Overall, HRQL
scores improved from baseline to study completion among
patients who completed the study.
The final model for KCCQ overall summary scores across all
visits is shown in Table 3. The two cohorts with EDS had signifi-
cantly lower KCCQ overall scores compared with the cohort
without either EDS or cognitive impairment; on average, the cog-
nitively impaired EDS cohort had a 33 point lower KCCQ score
(P , 0.001) and the non-impaired EDS cohort had a 25 point
lower KCCQ score (P ¼ 0.030). In addition, poor functional
class moderated the relationship between cohort membership
and HRQL. Subjects in NYHA classes III and IV had, on
average, 36 and 49 point lower KCCQ total scores than a com-
parable subject in class I or II (both P , 0.001), based on a total
possible score of 100. There were no significant interactions with
cohorts or over time. In results not shown in the table, the
cohort with both EDS and impaired cognition had significantly
worse KCCQ subscale scores compared with the cohort
without EDS or impaired cognition (P , 0.05), while the cohort
with only EDS had significantly worse physical limitation scores
(P ¼ 0.036).
The FOSQ total score final model across all visits is shown in
Table 4. Based on a total possible score of 20, the two cohorts
with EDS had 8 and 7 point lower FOSQ total scores, respectively,
compared with a similar subject in the cohort without EDS or
impaired cognition (both P , 0.001). Again, NYHA moderated
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the relationship between cohort membership and HRQL; subjects
in NYHA classes III and IV had, on average, 3 and 5 point lower
scores than a comparable subject in class I or II (P ¼ 0.017 and
P , 0.001, respectively). There were no significant interactions
with cohorts or over time. For the FOSQ subscale scores, both
cohorts with EDS had significantly higher general productivity
(with cognitive impairment, P , 0.001; without cognitive impair-
ment, P ¼ 0.016), activity level (both P , 0.001), and vigilance
(both P , 0.001) subscale scores (results not shown) compared
with the cohort without either EDS or cognitive impairment.
Discussion
Excessive daytime sleepiness contributes to HRQL, but when it is
combined with cognitive impairment it is even more powerful as a
predictor of poor HRQL in adults with HF. The double jeopardy of
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No EDS 1 CI
(n 5 51)
No EDS no CI
(n 5 55)
P-valuea
Age (years) 62.5+11.9 62.9+12.5 60.4+11.5 67.1+10.8 60.4+11.7 0.009
Male 152 (62.8) 48 (69.6) 35 (52.2) 33 (64.7) 36 (65.5) 0.187
Race/ethnicity 0.016
White 157 (64.9) 39 (56.5) 50 (74.6) 27 (52.9) 41 (74.6)
Black 77 (31.8) 28 (40.6) 15 (22.4) 20 (39.2) 14 (25.4)
Otherb 8 (3.3) 2 (2.9) 2 (3.0) 4 (7.8) 0 (0.0)
Education 0.011
Less than high school 23 (9.5) 8 (11.6) 3 (4.5) 10 (19.6) 2 (3.6)
High school 80 (33.1) 22 (31.9) 23 (34.3) 21 (41.2) 14 (25.5)
Some college 139 (57.4) 39 (56.5) 41 (61.2) 20 (39.2) 39 (70.9)
Body mass index 31.2+12.0 30.1+6.0 31.6+9.2 33.0+21 30.2+8.0 0.553
Financial status 0.281
More than enough to make ends
meet
86 (35.5) 22 (31.9) 26 (38.8) 21 (41.2) 17 (30.9)
Enough to make ends meet 119 (49.2) 35 (50.7) 28 (41.8) 22 (43.1) 34 (61.8)
Not enough to make ends meet 37 (15.3) 12 (17.4) 13 (19.4) 8 (15.7) 4 (7.3)
Employment status 0.001
Employed 68 (28.1) 11 (15.9) 28 (41.8) 12 (23.5) 17 (30.9)
Disability/unemployed 59 (24.4) 26 (37.7) 15 (22.4) 5 (9.8) 13 (23.6)
Retired/homemaker 115 (47.5) 32 (46.4) 24 (35.8) 34 (66.7) 25 (45.5)
Perceived overall health 0.002
Excellent/very good/good 116 (47.9) 25 (36.2) 45 (67.2) 22 (43.1) 24 (43.6)
Fair/poor 126 (52.1) 44 (63.8) 22 (32.8) 29 (56.9) 31 (56.4)
KCCQ Overall Summary Score 69.4+20.3 60.5+22.5 72.8+18.5 72.5+17.7 74.6+17.4 ,0.001
FOSQ Total score 17.4+2.6 16.0+2.8 17.6+2.2 18.2+2.1 18.5+2.2 ,0.001
Number of co-morbid conditions 3.1+2.1 3.5+2.1 2.5+2.1 3.8+2.2 2.8+1.7 0.003
Patient Health Questionnaire (PHQ2) 0.81+1.28 1.2+1.5 0.8+1.2 0.5+1.2 0.6+1.0 0.022
NYHA functional class 0.083
Classes I and II 86 (28.1) 11 (15.9) 20 (29.9) 16 (31.4) 21 (38.2)
Class III 143 (59.1) 44 (63.8) 39 (58.2) 31 (60.8) 29 (52.7)
Class IV 31 (12.8) 14 (20.3) 8 (11.9) 4 (7.8) 5 (9.1)
Months with heart failure at study
entry
75.2+73.7 66.0+58.6 70.1+62.3 70.8+70.3 98.0+101 0.373
Sleep-disordered breathing 137 (56.6) 39 (56.5) 41 (61.2) 27 (52.9) 30 (54.5) 0.84
Number of medicines known to cause
daytime somnolence
1.7+1.1 1.8+1.3 1.7 +1.2 1.6+1.0 1.5+1.0 0.65
Mean+ standard deviation or n (%) are reported.
CI, cognitive impairment; EDS, excessive daytime sleepiness; FOSQ, Functional Outcomes of Sleep Questionnaire; KCCQ, Kansas City Cardiomyopathy Questionnaire; NYHA,
New York Heart Association.
aComparison of groups via analysis of variance, Kruskal–Wallis, or x2 tests.
bOther category combined with Black for analysis.
Daytime sleepiness and impaired cognition impair quality of life in heart failure 733
EDS and impaired cognition was especially prominent in subjects
who were physically functionally impaired. These results suggest
that NYHA class III and class IV patients with HF should be sus-
pected of EDS and cognitive impairment. Also, those with cognitive
impairment and/or EDS may well have poor HRQL. We found no
differences in sleep-disordered breathing among the cohorts, illus-
trating that we cannot assume that HF patients with EDS are those
with sleep apnoea. Further research is needed to determine if
interventions can improve EDS and, if EDS improves, does
HRQL improve as well.
These results build on those from Pressler et al. who found that
impaired memory contributed only 1% of the variance in HRQL of
HF patients.8 In our study, we found that impaired cognition, which
includes memory, contributed significantly to HRQL but only
when combined with EDS. This suggests that it is the symptom
burden that affects HRQL more than changes in cognition, as sug-
gested by Heo et al.4 Pressler et al. also found that HF severity was
an important contributor to HRQL, consistent with our results
showing NYHA functional class as a moderator of the relationship
between cohort group and HRQL. Again, NYHA reflects symptom
burden, which continues to be identified as an important determin-
ant of poor HRQL.31,32
The finding that EDS contributes significantly to poor HRQL is
consistent with previous results demonstrating that poor sleep
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Table 2 Mean+ standard deviation for health-related quality of life total scores and subscales over time
Scale Enrolment (n 5 280) 3 Months (n 5 238) 6 Months (n 5 242) P-valuea
KCCQ Overall Summary Score 68.9+21.5 72.8+20.4 73.1+20.5 0.036
KCCQ Physical limitation score 69.2+23.8 72.7+22.1 72.5+23.2 0.194
KCCQ Symptom frequency score 74.4+22.5 77.3+21.6 78.0+21.7 0.070
KCCQ Symptom burden score 73.6+23.2 78.0+20.7 78.6+21.4 0.018
KCCQ Symptom stability score 57.5+22.3 56.3+20.4 51.4+21.6 0.003
KCCQ Total symptom score 74.0+22.0 77.7+20.3 78.3+20.4 0.038
KCCQ Quality of life score 65.1+25.1 69.4+24.3 71.4+22.1 0.016
KCCQ Social limitation score 66.0+28.2 70.8+26.9 69.7+28.0 0.117
KCCQ Clinical summary score 71.8+20.9 75.2+19.6 75.5+20.2 0.056
KCCQ Self-efficacy score 87.5+17.0 91.4+12.3 90.3+13.5 0.080
FOSQ Total score 17.3+2.8 17.9+2.4 17.8+2.4 0.040
FOSQ General productivity subscale score 3.6+0.6 3.7+0.5 3.7+0.5 0.400
FOSQ Social outcome subscale score 3.7+0.6 3.8+0.6 3.8+0.5 0.010
FOSQ Activity level subscale score 3.3+0.7 3.4+0.7 3.4+0.7 0.035
FOSQ Vigilance subscale score 3.4+0.8 3.6+0.6 3.6+0.6 0.018
FOSQ Intimacy subscale score 4.2+2.1 4.5+2.1 4.6+2.3 0.022
FOSQ, Functional Outcomes of Sleep Questionnaire; KCCQ, Kansas City Cardiomyopathy Questionnaire.
aKrusal–Wallis test for changes over time.
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Table 3 Final model for the Kansas City Cardiomyopathy Questionnaire overall summary score
Variable B estimate for transformed outcome 95 % CI B estimate on original scale P-value
Cohort 0.002
Cognitively impaired + /sleepy + –1066.8 –1656.7 to –476.8 –32.7 ,0.001
Cognitively impaired–/sleepy + –626.0 –1216.6 to –35.5 –25.0 0.038
Cognitively impaired + /sleepy– –254.8 –892.8 to 383.2 –16.0 0.432
Cognitively impaired–/sleepy– (ref)
NYHA functional class ,0.001
Class I– II (ref)
Class III –1306.6 –1602.3 to –1011.0 –36.1 ,0.001
Class IV –2411.2 –2858.0 to –1964.4 –49.1 ,0.001
Model adjusted for age, race, income, gender, data collection occasion, depressive symptoms, perceived health, visit occasion, and data collection site.
Square-transformed Kansas City Cardiomyopathy Questionnaire total score was modelled.
CI, confidence interval; NYHA, New York Heart Association.
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quality impairs HRQL in adults with HF.6,7 However, neither of
those investigative teams tested EDS as the symptom indicator
of poor HRQL. Identifying a symptom of focus is important
because screening for EDS is easy. As we showed in a previous
study in which four different approaches to measuring EDS were
compared, the measure of EDS that was most sensitive to
daytime dysfunction was a single Likert item measured on a
10-point (1–10) scale. Patients with a score ≥ 4 were 2.4 times
more likely to have daytime dysfunction than those with a score
,4.33 Adding this single question to a screening form at clinic
visits could help to identify patients needing intervention.
Few interventions for poor sleep have been tested in adults with
HF, and only sleep apnoea has received any significant testing.
However, results of the Canadian Continuous Positive Airway
Pressure for Patients with Central Sleep Apnea and Heart Failure
(CANPAP) trial were disappointing. Bradley and colleagues
tested the hypothesis that continuous positive airway pressure
(CPAP) would improve survival in adults with HF and central
sleep apnoea.34 After 3 months, the group randomized to CPAP
had fewer episodes of apnoea and hypopnoea, lower norepineph-
rine levels, and greater increases in the mean nocturnal oxygen sat-
uration, ejection fraction, and distance walked in 6 min, but
long-term outcomes were not improved at 2 years. There were
no differences between the control and CPAP groups in atrial
natriuretic peptide levels, HRQL, or the number of hospitaliza-
tions. The CANPAP study was stopped early for low enrolment.
Few other sleep-promoting approaches have been tested in HF
patients, and no other approach has been tested in anything other
than a pilot study or a small clinical trial. Preliminary research sug-
gests that exercise may improve total sleep time and HRQL;35
however, not all studies support this result.36 Further study is
needed to understand the effects of exercise on sleep and the
amount and type of exercise needed to have an effect. Fortunately,
such a trial is underway testing the effect of a supervised exercise
training programme in recently hospitalized HF patients attending a
disease management programme.37
Daytime sleepiness may be easier to influence than cognitive im-
pairment. Pressler reviewed studies of cognitive impairment in
adults with HF and concluded that 25–50% of HF patients have
impaired cognition.38 This impairment appears to differ from
typical vascular dementia in that some studies have shown that
cognition may improve over time in HF patients treated with
angiotensin-converting enzyme (ACE) inhibitor therapy or
aerobic exercise.39,40 Pressler et al. have had some preliminary
success in improving memory in HF patients with cognitive impair-
ment.41 HF patients were randomly assigned to a computerized
plasticity-based cognitive training intervention called Brain
Fitness. Compared with an active control intervention group re-
ceiving health education, the Brain Fitness participants improved
significantly over time in delayed recall memory, and both groups
improved over time in list learning, delayed recall memory, psycho-
motor speed, and performance of independent activities of daily
living.
The observation that HRQL improved over time in all of the
groups was surprising. Others have noted an increase in HRQL
over time even without an intervention, which they attributed to
passing through a high-risk period following hospitalization in
one study.42 We provided no intervention, nor were our partici-
pants necessarily recently hospitalized, so the improvement may
have been due to social desirability effects, better engagement in
care, reactivity to the measures, or behavioural activation due to
engagement in the study.
Limitations of this current study include limited generalizability,
as many patients were ineligible for inclusion in the study if the
cohort they qualified for was already full. This sample was also
younger, better educated, and more financially comfortable than
many HF patients in the general community. Strengths of the
study include the relatively large proportion of minority partici-
pants and the thoroughness with which HRQL and cognitive im-
pairment were measured.
In summary, in this study we demonstrated that EDS is asso-
ciated with poor HRQL, and the combination of EDS and impaired
cognition represents double jeopardy for HF patients. EDS is easily
screened and could be used to identify patients at risk for poor
HRQL. Testing of interventions designed to improve EDS in HF
patients is needed.
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Table 4 Final model for the Functional Outcomes of Sleep Questionnaire total score
Variable B estimate for transformed outcome 95% CI B estimate on original scale P-value
Cohort ,0.001
Cognitively impaired + /sleepy + –62.7 –83.3 to –42.2 –7.9 ,0.001
Cognitively impaired–/sleepy + –44.8 –65.2 to –24.4 –6.7 ,0.001
Cognitively impaired + /sleepy– –14.4 –36.6 to 7.8 –3.8 0.202
Cognitively impaired–/sleepy– (ref)
NYHA functional class 0.001
Class I– II (ref)
Class III –11.9 –21.3 to –2.5 –3.4 0.017
Class IV –27.5 –41.8 to –13.3 –4.9 ,0.001
Model adjusted for age, race, income, gender, data collection occasion, depressive symptoms, perceived health, visit, and data collection site.
Square-transformed Functional Outcomes of Sleep Questionnaire was modelled.
CI, confidence interval; NYHA, New York Heart Association.
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